Gapping down
In reaction to disappointing earnings/guidance: CEMI -5.3%, WAB -4.8%, KMB-2%
M&A news: YHOO -1.0% (confirms it will sell its operating business to Verizon (VZ) for ~$4.83 bln in cash)
Select metals/mining stocks trading lower: AG -1.9%, AUY -1.5%, NEM-1.3%, ABX -1.1%, GOLD -1%, GDX -1%, SLV -1%, AU -0.8%, .
Other news:
In reaction to disappointing earnings/guidance: CEMI -5.3%, WAB -4.8%, KMB-2%
M&A news: YHOO -1.0% (confirms it will sell its operating business to Verizon (VZ) for ~$4.83 bln in cash)
Select metals/mining stocks trading lower: AG -1.9%, AUY -1.5%, NEM-1.3%, ABX -1.1%, GOLD -1%, GDX -1%, SLV -1%, AU -0.8%, .
Other news:
- TBRA -64.5% (announces results from its CENTAUR Phase 2b clinical trial evaluating the efficacy and safety of cenicriviroc for the treatment of NASH in 289 adults with liver fibrosis; study did not meet primary endpoint)
- OCUL -13% (receives CRL from the FDA regarding its NDA for DEXTENZA)
- SC -6.3% (delays the release of its 2Q16 earnings release, co in discussions with current & previous independent accountants primarily related to the discount accretion and credit loss allowance methodologies)
- RDY -2.6% (still checking)
- CLB -1.6% (discloses in 10Q being contacted by the DOJ regarding an investigation into Unaoil)
Analyst comments:
- SBRA -2.6% (downgraded to Underperform from Neutral at BofA/Merrill)
- DATA -2.3% (downgraded to Hold from Buy at Deutsche Bank)
- AGCO -1.7% (downgraded to Underweight from Neutral at Piper Jaffray)
- CNHI -1.5% (downgraded to Underweight from Neutral at Piper Jaffray)
- DE -1.4% (downgraded to Underweight from Neutral at Piper Jaffray)